Tiziana Granted a Patent on Methods and Use of Anti-CD3 Monoclonal Antibodies for Treatment of Crohn’s Disease
Share Talk Bulletin Board Heroes, Friday 7th August 2020
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this video charting update.
Share Talk Bulletin Board Heroes, Monday 3rd August 2020
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this video charting update.
Share Talk Bulletin Board Heroes, Friday 31st July 2020
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this video charting update.
Tiziana Life Sci PLC (TILS.L) Update on Timings and Corporate Actions – Charting Update
New York/London, 30 July 2020 – Tiziana Life Sciences plc (“Tiziana”, AIM: TILS, NASDAQ: TLSA) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics for oncology, inflammation and
Share Talk Weekly Stock Market News, 26th July 2020
Share Talk highlighted no less than fifteen new company “52-wk high” across our social media platforms, the micro markets are healthy and delivering shareholder value. Watching the small-cap marker we
Is OKYO Pharma (OKYO.L) the next Tiziana Life Sciences (TILS.L)
Pharma stocks have strengthened in 2020
Tiziana Life Sciences plc (TILS.L) Director Appointment
New York/London, 20 July 2020 – Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS), a US and UK biotechnology company that focuses on the discovery and development of novel molecules
Share Talk Bulletin Board Heroes, Monday 20th July 2020
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this video charting update.
Share Talk Bulletin Board Heroes, Friday 17th July 2020
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this video charting update.
Tiziana Life Sci PLC (TILS.L) Submission of Patent Application
Tiziana Announces Submission of Patent Application on Use of Foralumab, the Only Fully Human Anti-CD3 Monoclonal Antibody, to Enhance Success of CAR-T Therapy
Share Talk Bulletin Board Heroes, Tuesday 14th July 2020
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this video charting update.